Erratum: Dissociating b-Amyloid from a7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes a7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer’s Disease Brain (The Journal of Neuroscience (2009) (10961–10973) DOI: 10.1523/JNEUROSCI.6088-08.2009);Dissociating β-amyloid from α7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes α7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain

Journal of Neuroscience

Volumn 29, Issue 35, 2009, Pages 10961-10973

  Wang, Hoau Yan ^a   Stucky, Andres ^a   Liu, Jingjing ^a   Shen, Changpeng ^a   Trocme Thibierge, Caryn ^b   Morain, Philippe ^b  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 (4 BROMOPHENYL) 2 OXOETHYL] 1 METHYLPYRIDIUM; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[12-28]; AMYLOID BETA PROTEIN[15-20]; BUNGAROTOXIN RECEPTOR; CALCIUM CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC AGENT; S 24795; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SYNAPTOSOME;

EID: 69749119522     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2307-21.2021     Document Type: Erratum

References (55)

1. Austen BM, Paleologou KE, Ali SA, Qureshi MM, Allsop D, El-Agnaf OM (2008) Designing peptide inhibitors for oligomerization and toxicology of Alzheimer's beta-amyloid peptide. Biochemistry 47:1984-1992. (Pubitemid 351287124)
2. Battaglia F, Wang HY, Ghilardi MF, Gashi E, Quartarone A, Friedman E, Nixon RA (2007) Cortical plasticity in Alzheimer's disease in humans and rodents. Biol Psychiatry 62:1405-1412. (Pubitemid 350180725)
3. Beracochea D, Boucard A, Trocme-Thibierge C, Morain P (2008) Improvement of contextual memory by S 24795 in aged mice: comparison with memantine. Psychopharmacology (Berl) 196:555-564.
4. Capsoni S, Giannotta S, Cattaneo A (2002) Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies. Mol Cell Neurosci 21:15-28. (Pubitemid 35178496)
5. Chen L, Yamada K, Nabeshima T, Sokabe M (2006) alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. Neuropharmacology 50:254-268. (Pubitemid 43100011)
6. Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, Takahashi K, Gallyas F, Tabira T (1999) Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med 5:560-564. (Pubitemid 29220216)
7. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DHS (2001) Evidence that neurons accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38:120-134.
8. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen HS, Lipton SA, Nakanishi N (1998) Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393:377-381. (Pubitemid 28269712)
9. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Tonali PA (2003) Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease: evidence of impaired glutamatergic neurotransmission? Ann Neurol 53:824; author reply 824-825.
10. Dougherty JJ, Wu J, Nichols RA (2003) β-Amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. J Neurosci 23:6740-6747. (Pubitemid 36951200)
11. Dziewczapolski G, Glogowski CM, Masliah E, Heinemann SF (2009) Deletion of the α7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J Neurosci 29:8805-8815.
12. Eriksen JL, Janus CG (2007) Plaques, tangles and memory loss in mouse models of neurodegeneration. Behav Genet 37:79-100.
13. Forloni G, Colombo L, Girola L, Tagliavini F, Samona M (2001) Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett 487:404-407.
14. Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA (2005) Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A 102:2273-2276. (Pubitemid 40279365)
15. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15-20. (Pubitemid 30644433)
16. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE (2006) Abnormally enhanced neuregulin 1-ErbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12:824-828. (Pubitemid 44050073)
17. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831-843. (Pubitemid 44828454)
18. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's disease. J Neuropathol Exp Neurol 56:1095-1097.
19. Inghilleri M, Conte A, Frasca V, Scaldaferri N, Gilio F, Santini M, Fabbrini G, Prencipe M, Berardelli A (2006) Altered response to rTMS in patients with Alzheimer's disease. Clin Neurophysiol 117:103-109. (Pubitemid 43099956)
20. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet 1:21-30.
21. Lagostena L, Trocme-Thibierge C, Morain P, Cherubini E (2008) The partial alpha7 nicotinic acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampus. Neuropharmacology 54:676-685.
22. Lee DH, Wang HY (2003) Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid1-40 and beta-amyloid1-42. J Neurobiol 55:25-30.
23. Lindner M, Hogan JB, Krause RG, Machet F, Bourin C, Hodges DB Jr, Corsa JA, Barten DM, Toyn JH, Stock DA, Rose GM, Gribkoff VK (2006) Soluble Aβ and cognitive function in aged F-344 rats and Tg2576 mice. Bev Brain Res 173:62-75. (Pubitemid 44572017)
24. Liu QS, Kawai H, Berg DK (2001) beta-Amyloid peptide blocks the response of alpha7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci U S A 48:4734-4739. (Pubitemid 32295045)
25. Lopez-Hernandez G, Placzek AN, Thinschimdt JS, Lestage P, Trocme-Thibierge C, Morain P, Papke RL (2007) Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneurons. Neuropharmacology 53:134-144. (Pubitemid 47125947)
26. Malenka RC, Nicoll RA (1993) NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci 16:521-527. (Pubitemid 23341961)
27. Marighetto A, Valerio S, Desmedt A, Philippin JN, Trocmé-Thibierge C, Morain P (2008) Comparative effects of the α7 nicotinic partial agonist, S 24795 and cholinesterase inhibitor donepezil against aging-related deficits in declarative and working memory in mice. Psychopharmacology (Berl) 197:499-508.
28. Masuda Y, Uemura S, Nakanishi A, Ohashi R, Takegoshi K, Shimizu T, Shirasawa T, Irie K (2008) Verification of the C-terminal intramolecular beta-sheet in Abeta42 aggregates using solid-state NMR: implication for potent neurotoxicity through the formation of radicals. Bioorg Med Chem Lett 18:3206-3210. (Pubitemid 351718339)
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944. (Pubitemid 14076461)
30. Nagele RG, D'Andrea MR, Anderson WJ, Wang HY (2002) Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110:199-211.
31. Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283:1571-1577. (Pubitemid 30161512)
32. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24:1063-1070. (Pubitemid 37487883)
33. Ono K, Hasegawa K, Yoshiike Y, Takashima A, Yamada M, Naiki H (2002) Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's β-amyloid fibrils in vitro. J Neurochem 81:434-440. (Pubitemid 34809322)
34. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21:RC120(1-5).
35. Piccini A, Russo C, Gliozzi A, Relini A, Vitali A, Borghi R, Giliberto L, Armirotti A, D'Arrigo C, Bachi A, Cattaneo A, Canale C, Torrassa S, Saido TC, Markesbery W, Gambetti P, Tabaton M (2005) β-Amyloid is different in normal aging and in Alzheimer's disease. J Biol Chem 280:34186-34192. (Pubitemid 41443143)
36. Pichat P, Bergis OE, Terranova JP, Urani A, Duarte C, Santucci V, Gueudet C, Voltz C, Steinberg R, Stemmelin J, Oury-Donat F, Avenet P, Griebel G, Scatton B (2007) SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychoparmacology 32:17-34. (Pubitemid 44967781)
37. Scheuer K, Maras A, Gattaz WF, Cairns N, Förstl H, Müller WE (1996) Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease. Dementia 7:210-214. (Pubitemid 26276522)
38. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synaptic loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875. (Pubitemid 46438992)
39. Shen L, Ji HF, Zhang HY (2008) Why is the C-terminus of Abeta(1-42) more unfolded than that of Abeta(1-40)? Clues from hydrophobic interaction. J Phys Chem B 112:3164-3167.
40. Slotkin TA, Seidler FJ, Crain BJ, Bell JM, Bissette G, Nemeroff CB (1990) Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer's disease: implications for etiology and therapy. Proc Natl Acad Sci U S A 87:2452-2455. (Pubitemid 20141756)
41. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051-1058. (Pubitemid 41061516)
42. Solomon B, Koppel R, Frankel D, Hannan-Aharon E (1997) Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci U S A 94:4109-4112. (Pubitemid 27180507)
43. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic prospective. Cell 120:545-555.
44. Verwer RW, Hermens WT, Dijkhuizen P, ter Brake O, Baker RE, Salehi A, Sluiter AA, Kok MJ, Muller LJ, Verhaagen J, Swaab DF (2002) Cells in human postmortem brain tissue slices remain alive for several weeks in culture. FASEB J 16:54-60.
45. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539. (Pubitemid 34288854)
46. Wang H, Friedman E (2001) Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder. Biol Psychiatry 50:364-370. (Pubitemid 32816950)
47. Wang HY, Yue TL, Feuerstein G, Friedman E (1994) Platelet-activating factor: diminished acetylcholine release from rat brain is mediated by a Gi protein. J Neurochem 63:1720-1725. (Pubitemid 24326213)
48. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity: implications for Alzheimer's disease pathology. J Biol Chem 275:5626-5632.
49. 1-42 binds selectively and with pico-molar affinity to α7 nicotinic acetylcholine receptors. J Neurochem 75:1155-1161.
50. Wang HY, Li W, Benedetti NJ, Lee DH (2003) α7 Nicotinic acetylcholine receptors α7 nicotinic acetylcholine receptors mediate β-amyloid peptidesinduced tau protein phosphorylation. J Biol Chem 278:31547-31553. (Pubitemid 37048332)
51. Wevers A, Monteggia L, Nowacki S, Bloch W, Schütz U, Lindstrom J, Pereira EF, Eisenberg H, Giacobini E, de Vos RA, Steur EN, Maelicke A, Albuquerque EX, Schröder H (1999) Expression of nicotinic acetylcholine receptor sub-units in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur J Neurosci 11:2551-2565. (Pubitemid 29292349)
52. Williams JM, Guévremont D, Kennard JT, Mason-Parker SE, Tate WP, Abraham WC (2003) Long-term regulation of N-methyl-D-aspartate receptor sub-units and associated synaptic proteins following hippocampal synaptic plasticity. Neuroscience 118:1003-1013.
53. Yamada K, Nabeshima T (2000) Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther 88:93-113. (Pubitemid 32057133)
54. Yamada K, Takayanagi M, Kamei H, Nagai T, Dohniwa M, Kobayashi K, Yoshida S, Ohhara T, Takuma K, Nabeshima T (2005) Effects of memantine and donepezil on amyloid β-induced memory impairment in a delayed-matching to position task in rats. Behav Brain Res 162:191-199. (Pubitemid 40828531)
55. Yamamoto T, Hirano A (1986) Acomparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 12:3-9.